Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial

Stroke imposes significant burdens on health services and society, and as such there is a growing need to assess the cost-effectiveness of stroke treatment to ensure maximum benefit is derived from limited resources. This study compared the cost-effectiveness of treating post-stroke upper limb spast...

Descripción completa

Detalles Bibliográficos
Autores principales: Shackley, Phil, Shaw, Lisa, Price, Christopher, van Wijck, Frederike, Barnes, Michael, Graham, Laura, Ford, Gary A., Steen, Nick, Rodgers, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528253/
https://www.ncbi.nlm.nih.gov/pubmed/23342679
http://dx.doi.org/10.3390/toxins4121415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528253/
https://www.ncbi.nlm.nih.gov/pubmed/23342679
http://dx.doi.org/10.3390/toxins4121415

Ejemplares similares